Gerald M. Segal

5.0k total citations · 1 hit paper
20 papers, 3.9k citations indexed

About

Gerald M. Segal is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Gerald M. Segal has authored 20 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Gerald M. Segal's work include Immune Response and Inflammation (4 papers), Cell Adhesion Molecules Research (4 papers) and Platelet Disorders and Treatments (3 papers). Gerald M. Segal is often cited by papers focused on Immune Response and Inflammation (4 papers), Cell Adhesion Molecules Research (4 papers) and Platelet Disorders and Treatments (3 papers). Gerald M. Segal collaborates with scholars based in United States and Switzerland. Gerald M. Segal's co-authors include J. Zimmermann, Nicholas Lydon, Brian Druker, Elisabeth Buchdunger, Shu Tamura, J W Adamson, V C Broudy, Kenneth Kaushansky, John M. Harlan and Penny Ballem and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Gerald M. Segal

20 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

1996 2.8k citations Brian Druker, Shu Tamura et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald M. Segal United States	13	2.5k	1.4k	953	846	628	20	3.9k
Shu Tamura Japan	8	2.5k 1.0×	1.6k 1.2×	1.0k 1.1×	1.1k 1.3×	713 1.1×	11	3.7k
Nikolas von Bubnoff Germany	31	2.0k 0.8×	1.3k 1.0×	1.1k 1.2×	683 0.8×	1.1k 1.8×	138	4.1k
Philipp le Coutre Germany	33	3.5k 1.4×	2.7k 2.0×	867 0.9×	1.8k 2.1×	831 1.3×	157	4.8k
Zbigniew Rudzki Australia	21	2.7k 1.1×	2.2k 1.6×	709 0.7×	1.5k 1.8×	586 0.9×	101	3.8k
Christopher A. Eide United States	28	2.3k 0.9×	1.6k 1.1×	1.6k 1.7×	725 0.9×	802 1.3×	97	3.9k
H. Kantarjian United States	29	2.4k 1.0×	2.1k 1.6×	995 1.0×	776 0.9×	637 1.0×	120	3.9k
Ellin Berman United States	31	2.2k 0.9×	992 0.7×	1.2k 1.3×	305 0.4×	1.2k 1.9×	99	3.8k
Miloslav Beran United States	38	3.3k 1.3×	2.6k 1.9×	2.0k 2.1×	382 0.5×	1.1k 1.7×	106	5.6k
Ronald Paquette United States	33	3.2k 1.3×	2.4k 1.7×	1.5k 1.6×	1.1k 1.3×	610 1.0×	119	5.0k
Prithviraj Bose United States	32	2.2k 0.9×	1.9k 1.4×	1.9k 2.0×	634 0.7×	709 1.1×	277	4.0k

Countries citing papers authored by Gerald M. Segal

Since Specialization

Citations

This map shows the geographic impact of Gerald M. Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald M. Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald M. Segal more than expected).

Fields of papers citing papers by Gerald M. Segal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald M. Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald M. Segal. The network helps show where Gerald M. Segal may publish in the future.

Co-authorship network of co-authors of Gerald M. Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald M. Segal. A scholar is included among the top collaborators of Gerald M. Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald M. Segal. Gerald M. Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Segal, Gerald M., et al.. (2015). Glomerular Endothelial Vesicles in a Renal Allograft. The American Journal of Surgical Pathology. 39(6). 864–869. 5 indexed citations

Bennett, William M., et al.. (2015). Early Post-transplant Lymphoproliferative Disease in the Donor Ureter Without Systemic Involvement: A Case Report. Transplantation Proceedings. 47(7). 2301–2303. 2 indexed citations

Druker, Brian, Shu Tamura, Elisabeth Buchdunger, et al.. (1996). Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells. Nature Medicine. 2(5). 561–566. 2773 indexed citations breakdown →

Segal, Gerald M., R.E. Magenis, Melissa A. Brown, et al.. (1994). Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells.. Journal of Clinical Investigation. 94(2). 846–852. 37 indexed citations

Segal, Gerald M., et al.. (1992). Comparison of granulocyte-macrophage colony stimulating factor and interleukin-1 production from human peripheral blood mononuclear cells as measured by specific radioimmunoassays.. PubMed. 3(4). 365–72. 6 indexed citations

Bagby, Grover C., Gray D. Shaw, Michael C. Heinrich, et al.. (1990). Interleukin-1 stimulation stabilizes GM-CSF mRNA in human vascular endothelial cells: preliminary studies on the role of the 3' AU rich motif.. PubMed. 352. 233–9. 12 indexed citations

Bagby, Grover C., Gray D. Shaw, & Gerald M. Segal. (1989). Human Vascular Endothelial Cells, Granulopoiesis, and the Inflammatory Response.. Journal of Investigative Dermatology. 93(s2). 48S–52S. 9 indexed citations

Bagby, Grover C., Gray D. Shaw, & Gerald M. Segal. (1989). Human Vascular Endothelial Cells, Granulopoiesis, and the Inflammatory Response. Journal of Investigative Dermatology. 93(2). S48–S52. 12 indexed citations

Segal, Gerald M., et al.. (1988). The anemia of end-stage renal disease: Hematopoietic progenitor cell response. Kidney International. 33(5). 983–988. 29 indexed citations

10.

Segal, Gerald M., et al.. (1988). Analysis of murine megakaryocyte colony size and ploidy: Effects of interleukin‐3. Journal of Cellular Physiology. 137(3). 537–544. 35 indexed citations

11.

Segal, Gerald M. & Grover C. Bagby. (1988). Vascular endothelial cells and hematopoietic regulation. The International Journal Of Cell Cloning. 6(5). 306–312. 12 indexed citations

12.

Ballem, Penny, Gerald M. Segal, Jon Stratton, et al.. (1987). Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.. Journal of Clinical Investigation. 80(1). 33–40. 318 indexed citations

13.

Segal, Gerald M., et al.. (1987). Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis. Kidney International. 31(1). 72–76. 21 indexed citations

14.

Segal, Gerald M., et al.. (1987). Interleukin 1 stimulates endothelial cells to release multilineage human colony-stimulating activity.. The Journal of Immunology. 138(6). 1772–1778. 72 indexed citations

15.

Broudy, V C, Kenneth Kaushansky, Gerald M. Segal, John M. Harlan, & J W Adamson. (1986). Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor.. Proceedings of the National Academy of Sciences. 83(19). 7467–7471. 324 indexed citations

16.

Kaushansky, K, Patrick J. O’Hara, Kathleen L. Berkner, et al.. (1986). Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor.. Proceedings of the National Academy of Sciences. 83(10). 3101–3105. 130 indexed citations

17.

Segal, Gerald M. & Larry G. Duckert. (1986). Reversible mechlorethamine-associated hearing loss in a patient with hodgkin's disease. Cancer. 57(6). 1089–1091. 3 indexed citations

18.

Delwiche, F., Gerald M. Segal, Joseph W. Eschbach, & John W. Adamson. (1986). Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificity. Kidney International. 29(3). 641–648. 38 indexed citations

19.

Abkowitz, Janis L., et al.. (1986). Multilineage, non‐species specific hematopoietic growth factor(s) elaborated by a feline fibroblast cell line: Enhancement by virus infection. Journal of Cellular Physiology. 127(1). 189–196. 15 indexed citations

20.

Ciaglia, P. & Gerald M. Segal. (1962). SEGMENTAL ESOPHAGECTOMY: ANCILLARY PROCEDURE FOR ADVANCED MEGAESOPHAGUS WITH SIGMOID ELONGATION. Journal of Thoracic and Cardiovascular Surgery. 44(1). 44–52. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact